Dr. Jasper de Boer leads strategic initiatives at the Australian and New Zealand Children’s Haematology and Oncology Group (ANZCHOG) to boost paediatric oncology research and clinical trials. Additionally, in his previous role as the Manager of the VCCC Alliance in Australia, he has extended his focus to adult cancer research and trials. His career, covering over two decades in research, clinical trials, and healthcare consulting, has led to significant contributions in medical innovation and therapy development. As the head of Novel Cancer Therapies at UCL Great Ormond Street Institute of Child Health, Dr. de Boer has employed genomics, in silico analyses, and biology to enhance diagnostics and treatments for paediatric cancers. His impactful work includes the development of targeted therapies for MLL-rearranged leukaemias, the inhibition of H3.3 mutated histones in diffuse midline gliomas, and the establishment of a sequencing-based MRD test for paediatric AML. Dr. de Boer's considerable output of peer-reviewed publications, together with his numerous invited talks, seminars, and conference presentations, demonstrates his pivotal role in the oncology field. Furthermore, his involvement in reviewing grant applications for funding bodies in Europe and Australia underscores his dedication and expertise in driving forward research in both paediatric and adult oncology.